ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 684409 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 684409; 2) Community: the network communities that were significantly associated with the response to NSC 684409; 3) Molecule: the relationships between components within communities and NSC 684409; 4) MDR: the compounds that were significantly associated with the NSC 684409.

NSC Compound Enrichment Correlation
NSC 691845 Null 0.000108541161925035 0.11232919
NSC 648365 Insulin-Methotrexate conjugate 0.000193456494459355 0.58164073
NSC 684567 4,6(1H,5H)-Pyrimidinedione, 5-[3-[4-(diethylamino)phenyl]- 2-propenylidene]-2,3-dihydro-2-thioxo- 0.000193456494459357 0.39241593
NSC 681642 Camptothecin Derivative 0.000305106126354733 0.34237034
NSC 626676 Null 0.000416348839396258 0.1938124
NSC 734296 6-(3-Bromopropyl)-5,6-dihydro-8,9-dimethoxy-3-nitro-5,11-dio xo-11H-indeno[1,2-c]isoquinoline 0.000416348839396261 0.33957467
NSC 731104 Null 0.000489907453833643 0.35136239
NSC 732517 Dasatinib 0.000584785790823213 -0.15480907
NSC 745813 Null 0.000584785790823213 0.26130295
NSC 737318 6-(3-Chloropropyl)-5,6-dihydro-2,3,9-trimethoxy-5,11-dioxo-1 1H-indeno[1,2-c]isoquinoline 0.000649370174092101 0.51642605
Total:94  Current:1    [First] [Prev] [Next] [Last]